Urine concentrating ability in sickle transgenic mice
. | βS % . | αH% . | γ% >9 wk . | Urine concentrate (mOsm) . |
---|---|---|---|---|
C57BL | 3147 ± 6533-150 | |||
CONTROL | — | — | — | 1688 ± 2333-151 |
C57BL Hbbth-1//Hbbth-1 | ||||
THAL | — | — | — | 2820 ± 4053-150 |
α2βSγ(G203)Hba0//Hba0Hbb0//Hbb0 | ||||
NY1KO γM | 80 | 100 | 20 | 1176 ± 1273-151b |
α2βSγ(G100)Hba0//Hba0Hbb0//Hbb0 | ||||
NY1KO γH | 60 | 100 | 40 | 3285 ± 3683-150,3-a |
α1GγAγδβSHba0//Hba0Hbb0//Hbb0 | ||||
BERK | >99 | 100 | <1 | 898 ± 2263-151b |
α1GγAγδβSγ(G203)Hba0//Hba0Hbb0//Hbb0 | ||||
BERK γM | 79 | 100 | 21 | 1710 ± 4743-151,3-a |
. | βS % . | αH% . | γ% >9 wk . | Urine concentrate (mOsm) . |
---|---|---|---|---|
C57BL | 3147 ± 6533-150 | |||
CONTROL | — | — | — | 1688 ± 2333-151 |
C57BL Hbbth-1//Hbbth-1 | ||||
THAL | — | — | — | 2820 ± 4053-150 |
α2βSγ(G203)Hba0//Hba0Hbb0//Hbb0 | ||||
NY1KO γM | 80 | 100 | 20 | 1176 ± 1273-151b |
α2βSγ(G100)Hba0//Hba0Hbb0//Hbb0 | ||||
NY1KO γH | 60 | 100 | 40 | 3285 ± 3683-150,3-a |
α1GγAγδβSHba0//Hba0Hbb0//Hbb0 | ||||
BERK | >99 | 100 | <1 | 898 ± 2263-151b |
α1GγAγδβSγ(G203)Hba0//Hba0Hbb0//Hbb0 | ||||
BERK γM | 79 | 100 | 21 | 1710 ± 4743-151,3-a |